Panther is unlocking the tremendous biological powers of our skin, delivering efficacious, shelf-stable treatments directly to customers. Panther's precisely engineered smart microarray patches (SmartMAPs) are designed to treat a wide range of conditions in Skin Health (cosmetics, medical aesthetics) and Systemic Health (infectious diseases, allergies, cancer, autoimmune diseases, metabolic disorders).
SmartMAPs facilitate effective tech-enabled customer experiences, and its AI platform provides valuable insights for improved patient outcomes and development of even better treatments. SmartMAPs are affordable to manufacture and distribute, and are easy to apply, resulting in greater access and market expansion. Panther is developing clinically proven products, the first of which launching in 2027.
Panther's platform is an open to skin health and therapeutic partners in order to widely deliver shelf-stable, data-centric treatments directly to those who need them. Contact us if you are interested in bringing a new treatment to market.
